+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Automation in the Molecular Diagnostics Market by Type (Amplification Automation, Analysis Automation, Extraction Automation), Application (Blood Screening, Genetic Testing, Infectious Diseases), End-use - Forecast 2024-2030- Product Image
Global Automation in the Molecular Diagnostics Market by Type (Amplification Automation, Analysis Automation, Extraction Automation), Application (Blood Screening, Genetic Testing, Infectious Diseases), End-use - Forecast 2024-2030- Product Image
Sale

Global Automation in the Molecular Diagnostics Market by Type (Amplification Automation, Analysis Automation, Extraction Automation), Application (Blood Screening, Genetic Testing, Infectious Diseases), End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967568
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Automation in the Molecular Diagnostics Market size was estimated at USD 11.75 billion in 2023, USD 13.54 billion in 2024, and is expected to grow at a CAGR of 15.79% to reach USD 32.81 billion by 2030.

Automation in molecular diagnostics refers to the use of advanced technologies and machinery to perform complex laboratory tests that detect and measure the presence of genetic materials, including DNA and RNA, in a patient's sample, including blood, saliva, and tissue. Unlike traditional methods that require significant manual effort and time, automation streamlines these processes, making them faster, more accurate, and capable of handling a large volume of tests simultaneously. The rising focus on personalized healthcare and precision medicine necessitates more efficient and accurate diagnostics. Moreover, the increasing incidence of chronic diseases worldwide boosts the demand for automated molecular diagnostics.

Various government programs and funding in healthcare infrastructure and research encourage the adoption of these technologies. However, the initial investment in automation technology can be prohibitive for smaller labs and institutions. Furthermore, continuous innovations in automation technology, such as high-throughput systems and AI integration, drive the market forward. Integrating AI and machine learning to enhance data analysis and interpretation in diagnostics poses significant opportunities for manufacturers.

Regional Insights

The United States and Canada are leading in the Americas region due to their advanced healthcare infrastructure, significant investment in research & development, and high healthcare expenditure per capita. The demand in these countries is accelerated by the need for quicker and more accurate diagnostic tests for a variety of diseases, including infectious diseases, cancer, and genetic disorders. There is a high emphasis on the integration of data management systems with diagnostic equipment to streamline workflows and improve patient outcomes.

The European Union countries show a strong trend towards adopting automated molecular diagnostics, driven by the availability of healthcare funding, stringent regulatory standards, and a high degree of awareness about advanced diagnostic solutions. Initiatives such as the EU's Horizon 2020 have supported research and innovation in healthcare, including molecular diagnostics, leading to the development of new technologies and systems. The Middle East is experiencing growth in adopting advanced healthcare technologies due to substantial healthcare investments in countries including Saudi Arabia & UAE. The APAC region, encompassing countries including China, Japan, and India, has shown remarkable growth in the adoption of automated molecular diagnostics. The growth is primarily driven by rising healthcare expenditure and, awareness about early disease detection, and government initiatives towards healthcare improvement.

Market Trends by Segment

  • Type: Increasing significance of amplification automation in high-throughput settings
  • End-use: Research institutions prefer highly customizable and scalable automation solutions

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Biocare Medical and Molecular Instruments Join Forces to Elevate Bioimaging Technologies

Biocare Medical, a company that manufactures automated instruments in the United States, has entered a strategic alliance with Molecular Instruments (MI), which is recognized for its revolutionary HCR imaging technology. This partnership is expected to redefine the standards in automated bioimaging by integrating MI's state-of-the-art HCR platform with Biocare Medical’s cutting-edge ONCORE Pro X instrument. The collaboration aims to push the boundaries of efficiency and precision in situ hybridization (ISH) and immunohistochemistry (IHC) applications, thereby accelerating research, drug development, and clinical diagnostics.

The Launch of BugCount Guardian by LuminUltra to Enhnace Industrial Microbial Monitoring

LuminUltra has recently unveiled its latest breakthrough, the BugCount Guardian. This innovative system represents the next generation of the company’s proprietary 2nd Generation ATP testing technology, acclaimed for its swift and accurate assessment of microbial activity across diverse applications. Unlike traditional methods that are labor-intensive and time-consuming, BugCount Guardian automates the entire process, from sample collection to analysis, offering real-time results and insights without human intervention.

Yourgene Health Unveils Revolutionary MagBench Technology for Enhanced Non-Invasive Prenatal Testing

Yourgene Health PLC has introduced the MagBench Automated DNA Extraction Instrument and Kit, a transformative solution for Sage customers in the Asia-Pacific and Middle East regions. Designed as a bench-top robotic workstation for cell-free DNA (cfDNA) extraction, MagBench is aligned with Yourgene’s Sage 32 NIPT Workflow, offering a seamless and efficient process from sample collection to reporting. It simplifies DNA extraction with its user-friendly touchscreen interface, built-in protocols, and compact design, facilitating a rapid, cost-effective, and reliable process.

Key Company Profiles

The report delves into recent significant developments in the Automation in the Molecular Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaltis S.r.l., altona Diagnostics GmbH, AstraGene, Becton, Dickinson and Company, Biocartis, bioMérieux S.A., Danaher Corporation, ELITech Group, F. Hoffmann-La Roche Ltd., Hologic, Inc., MEGAROBO technologies Co., Ltd., Meridian Bioscience, Molecular Devices, LLC, Mylab Discovery Solutions, QIAGEN N.V., QuidelOrtho Corporation, Revvity, Inc., Sansure Biotech Inc., Scispot.io Inc., Seegene, Inc., Siemens Healthineers AG, Tecan Group Ltd., The Festo Group, and Vela Diagnostics.

This research report offers invaluable insights into various crucial aspects of the Automation in the Molecular Diagnostics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising focus on personalized healthcare and precision medicine
5.1.1.2. Increasing incidence of chronic diseases across the globe
5.1.1.3. Upsurge in the need for point of care diagnostics
5.1.2. Restraints
5.1.2.1. High initial investment associated with automation technology
5.1.3. Opportunities
5.1.3.1. Continuous innovations in automation technology including high-throughput systems and AI integration
5.1.3.2. Government programs and funding in healthcare infrastructure and research
5.1.4. Challenges
5.1.4.1. Stringent regulations associated with the approval process
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing significance of amplification automation in high-throughput settings
5.2.2. End-use: Research institutions prefer highly customizable and scalable automation solutions
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Automation in the Molecular Diagnostics Market, by Type
6.1. Introduction
6.2. Amplification Automation
6.3. Analysis Automation
6.4. Extraction Automation
6.5. Post-analytical Automation
6.6. Pre-analytical Automation
7. Automation in the Molecular Diagnostics Market, by Application
7.1. Introduction
7.2. Blood Screening
7.3. Genetic Testing
7.4. Infectious Diseases
7.5. Oncology
8. Automation in the Molecular Diagnostics Market, by End-use
8.1. Introduction
8.2. Clinical Laboratories
8.3. Hospitals
8.4. Research Institutions
9. Americas Automation in the Molecular Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Automation in the Molecular Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Automation in the Molecular Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Biocare Medical and Molecular Instruments Join Forces to Elevate Bioimaging Technologies
12.3.2. The Launch of BugCount Guardian by LuminUltra to Enhnace Industrial Microbial Monitoring
12.3.3. Yourgene Health Unveils Revolutionary MagBench Technology for Enhanced Non-Invasive Prenatal Testing
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION AUTOMATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION AUTOMATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ANALYSIS AUTOMATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ANALYSIS AUTOMATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY EXTRACTION AUTOMATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY EXTRACTION AUTOMATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY POST-ANALYTICAL AUTOMATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY POST-ANALYTICAL AUTOMATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRE-ANALYTICAL AUTOMATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRE-ANALYTICAL AUTOMATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 57. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 62. CANADA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 63. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 68. MEXICO AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 91. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 96. CHINA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 97. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 102. INDIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 109. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 114. JAPAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 145. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 150. THAILAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 165. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 170. DENMARK AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 171. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 176. EGYPT AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 177. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 182. FINLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 183. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 188. FRANCE AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 189. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 194. GERMANY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 201. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 206. ITALY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 219. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 224. NORWAY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 225. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 230. POLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 231. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 236. QATAR AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 255. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 260. SPAIN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 266. SWEDEN AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 272. SWITZERLAND AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 273. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 278. TURKEY AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 290. UNITED KINGDOM AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 291. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 292. AUTOMATION IN THE MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Abbott Laboratories
  • Adaltis S.r.l.
  • altona Diagnostics GmbH
  • AstraGene
  • Becton, Dickinson and Company
  • Biocartis
  • bioMérieux S.A.
  • Danaher Corporation
  • ELITech Group
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • MEGAROBO technologies Co., Ltd.
  • Meridian Bioscience
  • Molecular Devices, LLC
  • Mylab Discovery Solutions
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Revvity, Inc.
  • Sansure Biotech Inc.
  • Scispot.io Inc.
  • Seegene, Inc.
  • Siemens Healthineers AG
  • Tecan Group Ltd.
  • The Festo Group
  • Vela Diagnostics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 13.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 32.81 Billion
Compound Annual Growth Rate15.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments), Technology (PCR, INAAT), Application (Oncology, Genetic Testing), Test Location, and Segment Forecasts, 2024-2030 - Product Image

Global Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments), Technology (PCR, INAAT), Application (Oncology, Genetic Testing), Test Location, and Segment Forecasts, 2024-2030

  • Report
  • 270 Pages
  • Global
From
U.S. Molecular Diagnostics Market Size, Share & Trends Analysis Report By Disease (Healthcare-associated Infections, Respiratory), By End-use (Hospital Core Laboratory, Decentralized Test Sites), And Segment Forecasts, 2023 - 2030 - Product Image

U.S. Molecular Diagnostics Market Size, Share & Trends Analysis Report By Disease (Healthcare-associated Infections, Respiratory), By End-use (Hospital Core Laboratory, Decentralized Test Sites), And Segment Forecasts, 2023 - 2030

  • Report
  • 100 Pages
  • United States
From
North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030 - Product Image

North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • North America
From
Molecular Diagnostics - Product Image

Molecular Diagnostics

  • Newsletter
  • 100 Pages
  • Global
Molecular Diagnostics - Global Strategic Business Report - Product Image

Molecular Diagnostics - Global Strategic Business Report

  • Report
  • 880 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.